Premium
This is an archive article published on May 10, 2014

GSK posts net profit at R172 cr in last quarter

The company said it has changed the accounting year from January-December to April-March.

GlaxoSmithKline Consumer Healthcare on Friday reported a 10 per cent rise in net profit from a year earlier to Rs 171.71 crore for the January-March quarter driven by greater product reach and supported by cost efficiencies.

The company’s net sales stood at Rs 1,079.09 crore for the January-March quarter, while the same was at Rs 939.86 crore in the previous fiscal, GlaxoSmithKline Consumer Healthcare said in a filing to the BSE.

The company said it has changed the accounting year from January-December to April-March.

Story continues below this ad

“Accordingly, current year’s financial statement of the company are for a period of fifteen months…These figures are therefore not comparable with those of the previous year ended December 31, 2012,” it added.

United Spirits to sell Whyte & Mackay whisky biz

Mumbai: United Spirits Ltd, controlled by Diageo, has agreed to sell its Whyte & Mackay whisky business to a unit of Philippine’s Emperador Inc for an enterprise value of £430 million.

The sale is being done to clear a UK regulatory hurdle related to Diageo’s acquisition of the company formerly controlled by Vijay Mallya. United Spirits board recommended that its indirectly-owned subsidiary United Spirits (Great Britain) Ltd consider the sale of Whyte & Mackay Group to Emperador UK Ltd.

“United Spirits has approved the sale and entered into the sale and purchase agreement with Emperador UK and Emperador Inc,” the company said in a BSE filing.

Story continues below this ad

However, the sale of Whyte & Mackay will be subject to Indian and UK regulatory approvals, including that of the RBI.

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement